**Sphenopalatine Neuralgia (Sluder’s Neuralgia)** Sphenopalatine neuralgia, also known as Sluder’s neuralgia, is characterized by severe pain in the distribution area of the sphenopalatine ganglion due to irritation of this structure. The sphenopalatine ganglion is primarily composed of sympathetic nerve fibers, which are distributed to the orbit, sphenoid sinus, ethmoid sinus, hard palate, soft palate, nasopharynx, tonsils, and upper gingiva. It governs general sensation and glandular secretion, and also provides parasympathetic postganglionic fibers to the lacrimal gland, regulating tear secretion. At present, the etiology and pathogenesis of this condition remain unclear, but it may be related to the extension of infection from areas such the paranasal sinuses to the ganglion.
I. Diagnostic Points
This condition commonly occurs in women aged 30–40 and is influenced by internal and external environmental factors. Attacks often occur at night, with pain typically manifesting as a burning severe sensation at one side of the nasal root and inner canthus, radiating deeply. Sometimes pain is also felt at the mastoid region, radiating to the neck. Common accompanying symptoms include conjunctival congestion, edema, photophobia, and scintillating scotomas. Nasal mucosa congestion and edema, nasal discharge or congestion may also occur. Each attack lasts 10–30 minutes, and in isolated cases can extend up to 2 hours. The attacks have a periodic pattern: sometimes occurring 3–4 times a day, once every two days, or even once every 1–2 weeks. Examination reveals marked tenderness at the orbital region, nasal root, and mastoid region.
II. Treatment
(I) Acupoints and Acupuncture Techniques
1. **LI20 (Yingxiang) (bilateral):** Located 0.5 cun lateral to the ala nasi, at the midpoint of the nasolabial groove. Using a No. 30 gauge, 1.5 cun filiform needle, after routine local disinfection, insert obliquely towards BL1 (Jingming) approximately 1.3 cun. Needle sensation: local distension and pain. 2. **TE17 (Yifeng) (bilateral):** Located posterior to the earlobe, in the depression between the mandibular angle and the mastoid process. Using a No. 30 gauge, 1.5 cun filiform needle, after routine local disinfection, insert towards the tip of the nose approximately 1.3 cun (be careful not to injure the carotid artery and vein when needling this point). Needle sensation: distension and pain in the mandibular region. 3. **LI4 (Hegu) (bilateral):** Located on the dorsum of the hand, between the 1st and 2nd metacarpal bones, near the midpoint of the radial side of the 2nd metacarpal bone. Using a No. 30 gauge, 2 cun filiform needle, after routine local disinfection, insert towards SI3 (Houxi) approximately 1.8 cun. Needle sensation: distension and pain in the palm.
(2) Methods
The patient is positioned in a sitting posture. The acupoints are inserted according to the standard technique, with needles retained for 40 minutes. During the retention, the needles are twirled once before removal. The treatment is administered once daily, with six sessions constituting one course of treatment. A three-day rest is taken before the next course begins.
2. Commentary
For such patients, the aforementioned treatment yields good results, with pain usually being largely relieved after 3 to 5 sessions. However, after recovery, recurrence often occurs due to emotional factors or infections of the nasopharynx and nasal sinuses. In these cases, the same treatment remains effective. Patients should be advised to regulate their mind and body and to enhance their physical fitness to prevent recurrence.
Clinical Presentation of Sphenopalatine Ganglion Neuralgia
Sphenopalatine ganglion neuralgia, historically termed Sluder’s neuralgia, presents with a distinctive constellation of symptoms that can be challenging to differentiate from other facial pain disorders. Patients typically experience severe, unilateral pain originating deep within the face, often centered around the orbit, nasal cavity, and maxillary region. The pain is characterized by its paroxysmal nature, with episodes lasting from minutes to several hours, and is frequently described as a burning, boring, or stabbing sensation. A key feature of sphenopalatine ganglion neuralgia symptoms is the involvement of autonomic manifestations, which include ipsilateral lacrimation, nasal congestion, rhinorrhea, and conjunctival injection. These autonomic signs are crucial for clinical recognition, as they reflect the ganglion’s role in parasympathetic innervation. The pain may radiate to the teeth, palate, occiput, or neck, often leading to misdiagnosis as dental pathology or migraine. Triggers such as stress, weather changes, or nasal irritation can precipitate attacks. Understanding these symptom patterns is essential for clinicians, as the overlap with trigeminal autonomic cephalalgias requires careful evaluation to ensure accurate diagnosis and appropriate management.
Diagnostic Framework for Sluder Neuralgia
Establishing a diagnosis of sphenopalatine ganglion neuralgia relies on specific clinical criteria and the exclusion of other conditions. The Sluder neuralgia diagnosis criteria are primarily based on the International Classification of Headache Disorders (ICHD) guidelines, which emphasize unilateral facial pain with autonomic features. Key diagnostic components include the presence of severe, paroxysmal pain in the distribution of the sphenopalatine ganglion, accompanied by at least one ipsilateral autonomic symptom such as lacrimation, nasal congestion, or periorbital edema. The pain must be reproducible by palpation of the pterygopalatine fossa or provocation through intranasal stimulation. Importantly, diagnosis requires ruling out alternative causes like sinusitis, dental infections, or trigeminal neuralgia through imaging studies (e.g., CT or MRI) and neurological examination. A diagnostic nerve block of the sphenopalatine ganglion can serve as a confirmatory tool, as temporary pain relief following the procedure supports the diagnosis. Clinicians must also consider the episodic nature of attacks, which typically last from 15 minutes to several hours, and the absence of structural lesions. Adherence to these criteria helps avoid misdiagnosis and ensures that patients receive targeted therapy for this debilitating condition.
Pharmacological and Interventional Treatment Options
Management of sphenopalatine ganglion neuralgia encompasses a range of pharmacological and interventional strategies tailored to symptom severity and frequency. First-line sphenopalatine ganglion neuralgia treatment options often include medications such as carbamazepine, gabapentin, or tricyclic antidepressants, which aim to modulate neuropathic pain pathways. For acute attacks, intranasal lidocaine or sumatriptan may provide rapid relief by targeting the ganglion locally. However, when pharmacotherapy proves insufficient or causes intolerable side effects, interventional approaches become critical. A sphenopalatine ganglion block for neuralgia is a minimally invasive procedure that delivers local anesthetic (e.g., bupivacaine) with or without corticosteroids to the pterygopalatine fossa, effectively interrupting nociceptive transmission. This block can be performed via transnasal, infrazygomatic, or intraoral approaches, offering both diagnostic and therapeutic benefits. Radiofrequency ablation or pulsed neuromodulation of the ganglion represents advanced options for refractory cases, providing longer-lasting relief by disrupting aberrant neural activity. The choice of treatment depends on individual patient factors, including comorbid conditions and response to prior therapies, emphasizing the need for a personalized, multidisciplinary approach.
Technique of the Sphenopalatine Neuralgia Nerve Block Procedure
The sphenopalatine neuralgia nerve block procedure is a targeted intervention designed to alleviate pain by anesthetizing the sphenopalatine ganglion. This procedure is typically performed in an outpatient setting under fluoroscopic or CT guidance to ensure accurate needle placement. The patient is positioned supine, and the pterygopalatine fossa is accessed via the infrazygomatic approach, where a 22-gauge needle is advanced toward the foramen rotundum. Alternatively, a transnasal technique using a cotton-tipped applicator soaked in anesthetic solution can be employed for a less invasive option. Once the needle tip is confirmed in correct anatomical position, a small volume (1-2 mL) of local anesthetic, such as lidocaine or bupivacaine, is injected. The block often produces immediate pain relief, validating the diagnosis and providing therapeutic benefit. Potential risks include bleeding, infection, or inadvertent spread of anesthetic to adjacent structures, though these are rare with proper technique. Post-procedure monitoring is essential to observe for adverse effects, and patients may experience temporary numbness or autonomic changes. This procedure is a cornerstone in managing refractory sphenopalatine ganglion neuralgia, offering a bridge to more durable treatments if needed.
Outcomes and Long-Term Management Strategies
Long-term outcomes for patients with sphenopalatine ganglion neuralgia depend on the integration of acute interventions with preventive strategies. Following a successful block, many patients experience significant pain reduction lasting weeks to months, though recurrence is common due to the chronic nature of the condition. Repeated sphenopalatine ganglion block for neuralgia can be performed, but clinicians often combine this with lifestyle modifications, such as avoiding triggers like alcohol or strong odors, and maintaining a pain diary. For patients with frequent, debilitating attacks, neuromodulation techniques like pulsed radiofrequency or sphenopalatine ganglion stimulation offer promising sustained results. These approaches work by altering the ganglion’s excitability, reducing the frequency and intensity of episodes. Additionally, psychological support and cognitive-behavioral therapy may help patients cope with chronic pain. Regular follow-up is crucial to monitor treatment efficacy and adjust medications as needed. Emerging research into the role of neuroinflammation and genetic factors may pave the way for more targeted therapies. Ultimately, a comprehensive management plan that combines interventional procedures, pharmacotherapy, and patient education optimizes quality of life for those living with this challenging neuralgia.